logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Biora Therapeutics, Inc.


USPTO Granted Patents = 17



Forward Citations = 8

Loading Chart...
Loading Chart...

29 inventors (with patents filed for the assignee):

goldMedal Mitchell Lawrence Jones (17 out of 36 patents)

silverMedal Christopher Loren Wahl (16 out of 26 patents)

bronzeMedal Sharat Singh (10 out of 100 patents)

4.  Harry Stylli (7 out of 17 patents)

5.  Mark Sasha Drlik (4 out of 20 patents)

6.  Nathan John Muller (4 out of 12 patents)

7.  Iman Niknia (4 out of 7 patents)

8.  Kevin Howe (4 out of 6 patents)

9.  Jeffrey A Shimizu (3 out of 7 patents)

10.  Tuyen Nguyen (3 out of 7 patents)

11.  Nicholas Mark Salt (3 out of 6 patents)

12.  Edward Mudge (3 out of 6 patents)

13.  Nia Eleri Stevens (3 out of 6 patents)

14.  Stuart Robert Abercrombie (3 out of 6 patents)

15.  Christopher Ian Bunce (3 out of 6 patents)


17 patents:

1. 12227565 - Method of formulating a pharmaceutical composition comprising administering an immune modulator to the small intestine (2025-02-18),
2. 12171764 - Treatment of a disease of the gastrointestinal tract with a JAK or other kinase inhibitor (2024-12-24),
3. 12150775 - Treatment of a disease of the gastrointestinal tract with an immunosuppressant (2024-11-26),
4. 12089916 - Gastrointestinal tract detection methods, devices and systems (2024-09-17),
5. 12053271 - Electromechanical pill device with localization capabilities (2024-08-06),
6. 11938295 - Ingestible device for delivery of therapeutic agent to the gastrointestinal tract (2024-03-26),
7. 11918342 - Localization systems and methods for an ingestible device (2024-03-05),
8. 11857669 - Treatment of a disease of the gastrointestinal tract with a JAK inhibitor and devices (2024-01-02),
9. 11793420 - Ingestible device for delivery of a dispensable substance (2023-10-24),
10. 11707610 - Ingestible device for delivery of therapeutic agent to the gastrointestinal tract (2023-07-25),
11. 11597762 - Treatment of a disease of the gastrointestinal tract with an IL-12/IL-23 inhibitor released using an ingestible device (2023-03-07),
12. 11596670 - Treatment of a disease of the gastrointestinal tract with IL-10 or an IL-10 agonist (2023-03-07),
13. 11547301 - Methods for collecting and testing bacteria containing samples from within the gastrointestinal tract (2023-01-10),
14. 11523772 - Treatment of a disease of the gastrointestinal tract with an immunosuppressant (2022-12-13),
15. 11471134 - Ingestible device recovery system (2022-10-18),
Company Overview
Biora Therapeutics, Inc. is a biotechnology company based in San Diego, California, focused on developing innovative therapeutic solutions. The company specializes in the intersection of biotechnology and medical devices, aiming to enhance drug delivery systems and improve patient outcomes. Biora's research emphasizes the creation of advanced oral and injectable delivery methods, leveraging proprietary technologies to address unmet medical needs in various therapeutic areas. Their commitment to innovation positions them as a key player in the evolving landscape of biopharmaceuticals.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

17 Patents

#339 in San Diego, CA

#4,509 in California

#18,881 in US

#35,887 in the World

San Diego, CA (US)
San Diego, CA, United States of America

Biora Therapeutics, Inc.

Forward Citations = 8

29 inventors:

goldMedal Mitchell Lawrence Jones (17 out of 36 patents)

silverMedal Christopher Loren Wahl (16 out of 26 patents)

bronzeMedal Sharat Singh (10 out of 100 patents)

4.  Harry Stylli (7 out of 17 patents)

5.  Mark Sasha Drlik (4 out of 20 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biora Therapeutics, Inc.. Retrieved from https://idiyas.com/company/biora-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…